Cargando…

Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis

OBJECTIVE: To assess the feasibility of a structured telephone interview examining the long-term cognitive and functional status in anti–leucine-rich, glioma-inactivated 1 (LGI1) encephalitis. METHODS: Telephone interviews were conducted with 37 patients after a median follow-up of 87 months from di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sola-Valls, Nuria, Ariño, Helena, Escudero, Domingo, Solana, Elisabeth, Lladó, Albert, Sánchez-Valle, Raquel, Blanco, Yolanda, Saiz, Albert, Dalmau, Josep, Graus, Francesc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943366/ https://www.ncbi.nlm.nih.gov/pubmed/31848230 http://dx.doi.org/10.1212/NXI.0000000000000652

Ejemplares similares

Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus
por: Sepulveda, Maria, et al.
Publicado: (2019)

Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity
por: Gresa-Arribas, Nuria, et al.
Publicado: (2015)

Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis
por: Ruiz-García, Raquel, et al.
Publicado: (2021)

Vanishing spinal cord after varicella-zoster virus myelitis
por: Sepúlveda, María, et al.
Publicado: (2017)

Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic: Experience From an Autoimmune Neurology Center
por: Ariño, Helena, et al.
Publicado: (2023)

Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer
por: Sabater, Lidia, et al.
Publicado: (2013)

The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested
por: Ruiz-García, Raquel, et al.
Publicado: (2020)

Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis
por: Guasp, Mar, et al.
Publicado: (2020)

Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-D-aspartate receptor antibodies are part of the problem
por: Höftberger, Romana, et al.
Publicado: (2013)

An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays
por: Höftberger, Romana, et al.
Publicado: (2013)

Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
por: Llufriu, Sara, et al.
Publicado: (2014)

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis
por: Balu, Ramani, et al.
Publicado: (2019)

Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere
por: Rachdi, Amine, et al.
Publicado: (2019)

Influence of Corpus Callosum Damage on Cognition and Physical Disability in Multiple Sclerosis: A Multimodal Study
por: Llufriu, Sara, et al.
Publicado: (2012)

Autoimmune Encephalitis and Related Syndromes
por: Graus, Francesc
Publicado: (2023)

Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies
por: Messelmani, Mariem, et al.
Publicado: (2015)

Clinical significance of Kelch-like protein 11 antibodies
por: Maudes, Estibaliz, et al.
Publicado: (2020)

Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
por: Guasp, Mar, et al.
Publicado: (2021)

Clinical neuropathology practice guide 5-2012: Updated guideline for the diagnosis of anti-neuronal antibodies
por: Höftberger, Romana, et al.
Publicado: (2012)

Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia
por: Yuan, Xiaoling, et al.
Publicado: (2020)

Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit
por: Sepúlveda, Maria, et al.
Publicado: (2021)

Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells
por: Mannara, Francesco, et al.
Publicado: (2012)

Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series
por: Joubert, Bastien, et al.
Publicado: (2020)

Leucine-rich glioma-inactivated protein 1 antibody encephalitis: A case report
por: Mayasi, Yunis, et al.
Publicado: (2014)

Motor Phenomena Associated With Leucine-Rich Glioma-Inactivated (LGI1) Emi-Encephalitis
por: Giorelli, Maurizio, et al.
Publicado: (2023)

Liver injury and glatiramer acetate, an uncommon association: case report and literature review
por: Almeida, Javier, et al.
Publicado: (2017)

The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined
por: Muñoz-Sánchez, Guillermo, et al.
Publicado: (2022)

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome
por: Sabater, Lidia, et al.
Publicado: (2016)

Structural networks involved in attention and executive functions in multiple sclerosis
por: Llufriu, Sara, et al.
Publicado: (2016)

Anti-Leucine-Rich Glioma-Inactivated 1 (Anti-LGI 1) Limbic Encephalitis and New-Onset Psychosis: A Case Report
por: Alho, António, et al.
Publicado: (2023)

Reversible Bilateral Striatal Hypermetabolism in a Patient with Leucine-Rich Glioma Inactivated-1 Encephalitis
por: Takkar, Aastha, et al.
Publicado: (2016)

Long latency between GAD-antibody detection and development of limbic encephalitis – a case report
por: Fauser, Susanne, et al.
Publicado: (2015)

Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis
por: Solana, Elisabeth, et al.
Publicado: (2018)

Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
por: Cellucci, Tania, et al.
Publicado: (2020)

Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
por: Murayama, Aki, et al.
Publicado: (2022)

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
por: Lin, You-ting, et al.
Publicado: (2019)

Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
por: Binks, Sophie N. M., et al.
Publicado: (2021)

Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature
por: Karvigh, Sanaz Ahmadi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n4i7ae08kvo08nrjun4b402dc6